These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 27384677

  • 1. Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells.
    Avino S, De Marco P, Cirillo F, Santolla MF, De Francesco EM, Perri MG, Rigiracciolo D, Dolce V, Belfiore A, Maggiolini M, Lappano R, Vivacqua A.
    Oncotarget; 2016 Aug 16; 7(33):52710-52728. PubMed ID: 27384677
    [Abstract] [Full Text] [Related]

  • 2. Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells.
    Vella V, Malaguarnera R, Nicolosi ML, Palladino C, Spoleti C, Massimino M, Vigneri P, Purrello M, Ragusa M, Morrione A, Belfiore A.
    Oncotarget; 2017 Jun 27; 8(26):43248-43270. PubMed ID: 28591735
    [Abstract] [Full Text] [Related]

  • 3. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R, Palladino C, Nicolosi ML, Lo Presti AR, Malaguarnera R, Ragusa M, Sciortino D, Morrione A, Maggiolini M, Vella V, Belfiore A.
    Oncotarget; 2016 Feb 16; 7(7):7683-700. PubMed ID: 26655502
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer.
    Belfiore A, Malaguarnera R, Nicolosi ML, Lappano R, Ragusa M, Morrione A, Vella V.
    Cell Adh Migr; 2018 Feb 16; 12(4):305-314. PubMed ID: 29486622
    [Abstract] [Full Text] [Related]

  • 7. Novel cross talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses.
    Malaguarnera R, Nicolosi ML, Sacco A, Morcavallo A, Vella V, Voci C, Spatuzza M, Xu SQ, Iozzo RV, Vigneri R, Morrione A, Belfiore A.
    Oncotarget; 2015 Jun 30; 6(18):16084-105. PubMed ID: 25840417
    [Abstract] [Full Text] [Related]

  • 8. DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop.
    Vella V, Nicolosi ML, Cantafio P, Massimino M, Lappano R, Vigneri P, Ciuni R, Gangemi P, Morrione A, Malaguarnera R, Belfiore A.
    Endocr Relat Cancer; 2019 Jan 01; 26(1):197-214. PubMed ID: 30121624
    [Abstract] [Full Text] [Related]

  • 9. GPER activates Notch signaling in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Pupo M, Pisano A, Abonante S, Maggiolini M, Musti AM.
    Int J Biochem Cell Biol; 2014 Jan 01; 46():56-67. PubMed ID: 24275097
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anti-inflammatory effect of IGF-1 is mediated by IGF-1R cross talk with GPER in MPTP/MPP+-induced astrocyte activation.
    Yuan LJ, Zhang M, Chen S, Chen WF.
    Mol Cell Endocrinol; 2021 Jan 01; 519():111053. PubMed ID: 33035625
    [Abstract] [Full Text] [Related]

  • 12. Cross-talk between GPER and growth factor signaling.
    Lappano R, De Marco P, De Francesco EM, Chimento A, Pezzi V, Maggiolini M.
    J Steroid Biochem Mol Biol; 2013 Sep 01; 137():50-6. PubMed ID: 23542661
    [Abstract] [Full Text] [Related]

  • 13. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
    Rigiracciolo DC, Santolla MF, Lappano R, Vivacqua A, Cirillo F, Galli GR, Talia M, Muglia L, Pellegrino M, Nohata N, Di Martino MT, Maggiolini M.
    J Exp Clin Cancer Res; 2019 Feb 06; 38(1):58. PubMed ID: 30728047
    [Abstract] [Full Text] [Related]

  • 14. DDR1 Affects Metabolic Reprogramming in Breast Cancer Cells by Cross-Talking to the Insulin/IGF System.
    Vella V, Giuliano M, Nicolosi ML, Majorana MG, Marć MA, Muoio MG, Morrione A, Maggiolini M, Lappano R, De Francesco EM, Belfiore A.
    Biomolecules; 2021 Jun 22; 11(7):. PubMed ID: 34206590
    [Abstract] [Full Text] [Related]

  • 15. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
    De Francesco EM, Sims AH, Maggiolini M, Sotgia F, Lisanti MP, Clarke RB.
    Breast Cancer Res; 2017 Dec 06; 19(1):129. PubMed ID: 29212519
    [Abstract] [Full Text] [Related]

  • 16. The Emerging Role of Insulin Receptor Isoforms in Thyroid Cancer: Clinical Implications and New Perspectives.
    Vella V, Malaguarnera R.
    Int J Mol Sci; 2018 Nov 30; 19(12):. PubMed ID: 30513575
    [Abstract] [Full Text] [Related]

  • 17. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
    Santolla MF, Avino S, Pellegrino M, De Francesco EM, De Marco P, Lappano R, Vivacqua A, Cirillo F, Rigiracciolo DC, Scarpelli A, Abonante S, Maggiolini M.
    Cell Death Dis; 2015 Jul 30; 6(7):e1834. PubMed ID: 26225773
    [Abstract] [Full Text] [Related]

  • 18. G protein-coupled oestrogen receptor promotes cell growth of non-small cell lung cancer cells via YAP1/QKI/circNOTCH1/m6A methylated NOTCH1 signalling.
    Shen Y, Li C, Zhou L, Huang JA.
    J Cell Mol Med; 2021 Jan 30; 25(1):284-296. PubMed ID: 33237585
    [Abstract] [Full Text] [Related]

  • 19. New advances on the functional cross-talk between insulin-like growth factor-I and estrogen signaling in cancer.
    Bartella V, De Marco P, Malaguarnera R, Belfiore A, Maggiolini M.
    Cell Signal; 2012 Aug 30; 24(8):1515-21. PubMed ID: 22481093
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.